This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Implicit parasitic Sepsis
AB1_SEPSIS_PARAS_IMPL
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditions
|
71805 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
210 |
4. Check minimum number of eventsNone |
210 |
5. Include endpointsNone |
210 |
6. Filter based on genotype QC (FinnGen only) |
185 |
Control definitions (FinnGen only)
- Control exclude
- AB1_SEPSIS_EXPLICIT, AB1_SEPSIS_IMPLICIT
Extra metadata
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Implicit parasitic Sepsis
based on the number of shared cases.
Similar with more cases:
- Implicit parasitic Sepsis, including avohilmo
- Implicit Sepsis
- Implicit Sepsis, including avohilmo
- Condition for Implicit Sepsis (Organ dysfunction codes)
- Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 185 | 103 | 82 |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | 0.04 |
| Median age at first event (years) | 53.25 | 50.84 | 56.28 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 190
- Matched controls
- 1900
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R55
ICD-10 Finland
Syncope and collapse
30.3
115.9
91
56
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
11.4
45.8
56
67
AA1AD
NOMESCO Finland
CT of head and brain
5.1
27.6
98
330
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
5.2
25.4
72
200
A07.8
ICD-10 Finland
Other specified protozoal intestinal diseases
273.0
24.2
24
*
N17.9
ICD-10 Finland
Acute renal failure, unspecified
143.1
24.2
25
*
A06.9
ICD-10 Finland
Amoebiasis, unspecified
+∞
20.2
19
*
A07.1
ICD-10 Finland
Giardiasis [lambliasis]
209.9
18.9
19
*
R50.9
ICD-10 Finland
Fever, unspecified
4.6
18.2
54
152
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
4.3
18.1
62
194
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.8
17.6
126
646
R51.80
ICD-10 Finland
Headache
4.0
16.0
58
188
TPH04
NOMESCO Finland
Cathetrisation of vein
3.7
15.7
68
248
P01AB01
ATC
metronidazole; oral, rectal
3.4
15.3
107
525
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.4
15.1
81
338
J01MA12
ATC
levofloxacin; systemic
3.7
14.8
60
209
D64.9
ICD-10 Finland
Anaemia, unspecified
4.6
14.2
38
97
XF400
NOMESCO Finland
ECG with 12 standard connections
3.8
13.8
53
177
A07.9
ICD-10 Finland
Protozoal intestinal disease, unspecified
150.3
13.6
14
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.7
13.4
52
175
C03CA01
ATC
furosemide; systemic
3.2
13.3
81
360
R06.0
ICD-10 Finland
Dyspnoea
3.1
12.9
80
358
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.0
12.7
42
126
A41.9
ICD-10 Finland
Sepsis, unspecified
138.8
12.6
13
*
J01FF01
ATC
clindamycin; systemic
3.1
12.4
72
309
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
5.1
12.4
28
62
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
4.1
12.3
39
113
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.7
11.6
23
45
H02AB06
ATC
prednisolone; systemic
2.9
11.4
111
625
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.3
11.4
55
211
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.5
11.0
45
155
A28
ICPC
Limited function/disability NOS
3.3
10.8
50
186
N05BA01
ATC
diazepam; systemic, rectal
3.7
10.8
40
129
E0000UV, ,
ATC
2.7
10.6
100
549
A06.0
ICD-10 Finland
Acute amoebic dysentery
+∞
10.5
10
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.7
10.4
89
464
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.9
10.3
66
295
A06AC01
ATC
ispaghula (psylla seeds); oral
2.9
10.3
67
302
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
3.4
10.2
44
156
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.5
10.2
41
139
A10AB05
ATC
insulin aspart; parenteral
4.5
10.1
26
64
W19
ICD-10 Finland
Unspecified fall
4.0
10.0
31
88
UJF32
NOMESCO Finland
Coloscopy
2.8
9.9
65
294
Z2221
NOMESCO Finland
Medical doctor
2.8
9.8
70
331
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
3.7
9.8
35
110
JN4AD
NOMESCO Finland
Body CT examination
3.7
9.8
35
110
A04
ICPC
Weakness/tiredness general
3.2
9.7
47
179
E86
ICD-10 Finland
Volume depletion
13.3
9.6
16
13
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
5.1
9.6
21
45
UJF30
NOMESCO Finland
Ileoscopy through colon
3.7
9.5
34
107
1369X
ICD-9 Finland
Other and unspecified infectious and parasitic diseases, Unspecified infectious and parasitic diseases
+∞
9.4
9
*
B54
ICD-10 Finland
Unspecified malaria
+∞
9.4
9
*
H02AB07
ATC
prednisone; oral
3.6
9.4
35
113
Z01.8
ICD-10 Finland
Other specified special examinations
2.9
9.2
54
229
J01MA02
ATC
ciprofloxacin; systemic
2.5
8.9
89
491
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.9
8.9
50
207
R42
ICD-10 Finland
Dizziness and giddiness
2.7
8.8
61
281
WX002
NOMESCO Finland
Sedation and analgesia
2.9
8.8
51
214
L04AA01
ATC
[U] ciclosporin
52.5
8.8
10
*
L28
ICPC
Limited function/disability (L)
2.9
8.7
49
202
N02AA05
ATC
oxycodone; systemic
2.9
8.7
49
202
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
4.6
8.7
22
53
C03DA01
ATC
spironolactone; oral
3.4
8.7
34
113
R4110
NOMESCO Finland
Physiotherapy
2.6
8.7
72
363
J01MA06
ATC
norfloxacin; oral
3.2
8.6
38
136
127
Kela drug reimbursment
Transplant complication
29.0
8.6
11
*
A02BC05
ATC
esomeprazole; systemic
2.5
8.4
91
517
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
4.6
8.4
21
50
N17
ICPC
Vertigo/dizziness
3.2
8.4
38
138
R5140
NOMESCO Finland
Monitoring the use of the aid
3.3
8.4
35
121
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
+∞
8.4
8
*
R53
ICD-10 Finland
Malaise and fatigue
2.6
8.3
68
339
N05CF01
ATC
zopiclone; oral
2.5
8.3
77
408
N05CD07
ATC
temazepam; oral
3.3
8.3
35
122
A10AC01
ATC
insulin (human); parenteral
4.2
8.2
23
60
I50.9
ICD-10 Finland
Heart failure, unspecified
3.1
8.2
38
140
A10AE04
ATC
insulin glargine; parenteral
3.7
8.2
28
85
103
Kela drug reimbursment
Diabetes, insulin-treated
2.6
8.1
63
307
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.5
8.0
76
405
N30.0
ICD-10 Finland
Acute cystitis
3.0
8.0
42
166
A06AD11
ATC
lactulose; oral
3.1
8.0
37
136
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
3.5
7.9
29
92
R06AE07
ATC
cetirizine; oral
2.4
7.9
97
579
J96.1
ICD-10 Finland
Chronic respiratory failure
46.9
7.8
9
*
S06.0
ICD-10 Finland
Concussion
3.2
7.8
34
121
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.7
7.7
51
228
A02BC01
ATC
omeprazole; systemic
2.5
7.7
64
321
N06AX21
ATC
duloxetine; oral
3.2
7.7
34
122
FPE20
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes
7.0
7.6
18
28
H02AB04
ATC
methylprednisolone; systemic
3.0
7.6
39
152
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
4.0
7.6
23
64
A11
ICPC
Chest pain NOS
3.5
7.5
28
90
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
7.4
7.5
17
25
Z3226
NOMESCO Finland
Physiotherapist
2.7
7.5
49
218
H32.0*B58.0
ICD-10 Finland
Toxoplasma chorioretinitis
83.2
7.5
8
*
B50.9
ICD-10 Finland
Plasmodium falciparum malaria, unspecified
83.2
7.5
8
*
R07.4
ICD-10 Finland
Chest pain, unspecified
2.4
7.5
69
362
R11
ICD-10 Finland
Nausea and vomiting
3.5
7.5
27
85
B01AA03
ATC
warfarin; systemic
2.7
7.5
47
205
SPAT1229
SPAT
Assessment of need for aid
4.0
7.4
22
60
XF404
NOMESCO Finland
Ambulatory ECG
3.7
7.4
25
75
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.7
7.4
25
75
N05CF02
ATC
zolpidem; oral
2.8
7.4
44
186
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
4.6
7.4
18
42
N05AH04
ATC
quetiapine; oral
2.7
7.4
45
193
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
16.6
7.3
11
7
D06
ICPC
Abdominal pain localized other
3.6
7.3
26
81
ZXE10
NOMESCO Finland
More than one and less than three hours
2.3
7.3
80
452
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.6
7.3
25
76
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
3.0
7.2
36
138
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
21.0
7.2
10
5
N06CA01
ATC
amitriptyline and psycholeptics; systemic
3.3
7.2
29
98
D11
ICPC
Diarrhoea
3.0
7.1
36
139
R56.8
ICD-10 Finland
Other and unspecified convulsions
4.7
7.1
17
39
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
3.7
7.1
24
72
J45.9
ICD-10 Finland
Asthma, unspecified
2.6
7.1
48
217
N06AA09
ATC
amitriptyline; systemic
3.3
7.1
29
99
SPAT1255
SPAT
Intravenous administration of medicine
4.4
7.0
18
44
A10AE05
ATC
insulin detemir; parenteral
4.4
7.0
18
44
XF402
NOMESCO Finland
ECG with work load test
3.2
6.9
29
100
ZX120
NOMESCO Finland
Intravenous
3.3
6.9
28
95
C07AB07
ATC
bisoprolol; oral
2.2
6.9
107
694
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
6.9
6.8
16
25
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
3.2
6.8
28
96
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.2
6.8
28
96
C07AB02
ATC
metoprolol; systemic
2.6
6.7
48
222
C07AG02
ATC
carvedilol; oral
3.9
6.7
20
55
H04AA01
ATC
glucagon; nasal, parenteral
9.2
6.7
13
15
N03AX09
ATC
lamotrigine; oral
5.7
6.7
18
34
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.7
6.6
22
65
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.3
6.6
27
92
D20
ICPC
Mouth/tongue/lip symptom/complaint
4.0
6.5
19
51
L04AA06
ATC
mycophenolic acid; systemic
15.0
6.5
10
7
Z94.0
ICD-10 Finland
Kidney transplant status
72.2
6.5
7
*
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
6.4
6.5
16
27
E000001, ,
ATC
2.5
6.5
48
226
SPAT1262
SPAT
Handing over of treatment supplies
2.7
6.4
39
166
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.4
6.4
55
277
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.6
6.4
44
200
N02AX02
ATC
tramadol; systemic, rectal
2.2
6.3
91
566
A02BC03
ATC
lansoprazole; oral
2.3
6.3
65
353
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
2.5
6.3
47
221
A29
ICPC
General symptom/complaint other
2.8
6.3
35
142
N03AX16
ATC
[U] pregabalin
2.4
6.3
54
271
B58.9
ICD-10 Finland
Toxoplasmosis, unspecified
+∞
6.3
6
*
J96.0
ICD-10 Finland
Acute respiratory failure
+∞
6.3
6
*
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
+∞
6.3
6
*
H04.10
ICD-10 Finland
Dry eye syndrome
2.8
6.2
35
143
N06AX11
ATC
mirtazapine; oral
2.2
6.2
77
451
Z71.8
ICD-10 Finland
Other specified counselling
2.2
6.2
77
451
I20.99
ICD-10 Finland
Angina pectoris, unspecified
3.7
6.2
20
58
XW000
NOMESCO Finland
Bone marrow biopsy
5.6
6.2
17
33
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
10.5
6.1
11
11
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.6
6.1
38
164
K59.09
ICD-10 Finland
Constipation, unspecified
3.6
6.1
21
64
I50.0
ICD-10 Finland
Congestive heart failure
3.7
6.1
20
59
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
44
49
11.38
37.53
3.3
1.6
—
—
—
0
0
46
93
6.21
22.97
2.3
1.5
—
—
—
0
0
35
54
7.72
22.61
1.5
1.6
1.21
6.26
ug/l
0.46
28
46
68
228
4.09
18.09
3.2
1.8
—
—
—
0
0
55
166
4.26
16.77
2.9
1.7
—
—
—
0
0
53
161
4.18
15.96
3.1
1.8
—
—
—
0
0
66
239
3.70
15.41
3.8
2.3
2.19
2.30
g/l
0.65
60
218
51
159
4.02
14.73
7.9
2.8
1.51
1.86
mmol/l
0.30
46
137
126
706
3.33
14.04
8.8
4.1
33.80
36.19
g/l
3.96
120
667
32
73
5.07
13.69
2.5
1.7
—
—
—
0
0
68
269
3.38
13.62
3.8
2.3
9.77
13.39
umol/l
3.17
62
246
23
39
6.57
13.40
1.8
1.5
—
—
—
0
0
110
592
3.04
12.73
5.7
2.9
—
—
—
0
0
70
293
3.20
12.64
4.4
3.5
470.26
392.39
ng/l
0.10
57
221
95
474
3.01
12.58
5.5
2.9
0.27
0.28
e6/l
0.02
64
333
140
879
3.25
12.01
11.5
5.9
10.19
11.44
umol/l
1.30
135
829
49
170
3.54
11.91
13.8
6.2
0.73
0.85
mmol/l
0.07
39
144
133
818
3.09
11.70
17.2
5.7
1.21
1.21
mmol/l
0.37
124
700
67
287
3.06
11.47
4.7
2.7
1.10
0.86
e6/l
0.21
32
149
63
262
3.10
11.34
4.8
2.8
4.12
1.79
e6/l
0.47
26
126
41
131
3.72
11.24
4.2
2.6
64.52
67.04
g/l
1.51
36
126
76
364
2.81
10.46
2.7
1.7
1.43
1.21
mg/l
0.24
65
287
22
46
5.28
10.30
1.5
1.3
—
—
—
0
0
142
956
2.92
9.67
11.3
4.1
7.03
6.61
mmol/l
1.14
136
899
19
37
5.59
9.58
2.5
1.5
—
—
—
0
0
78
393
2.67
9.57
4.6
2.9
346.69
336.87
umol/l
0.35
67
339
21
46
5.01
9.31
2.2
4.2
1.30
3.03
ratio
0.70
11
24
90
492
2.58
9.28
2.3
1.7
17.00
21.47
nmol/l
2.50
80
401
167
1250
3.78
9.07
14.3
7.2
75.76
79.12
u/l
0.66
160
1169
13
7
19.81
9.07
2.2
1.3
—
—
—
0
0
81
425
2.58
9.05
3.4
2.0
2.70
2.81
mg/l
0.20
74
360
92
513
2.54
9.04
3.9
2.2
57.13
76.54
u/l
0.88
82
467
31
96
3.66
8.80
7.2
2.3
1.67
1.87
mmol/l
0.10
24
75
13
8
17.31
8.68
2.2
1.4
—
—
—
0
0
114
722
2.45
8.24
3.5
2.4
76.97
76.86
nmol/l
0.02
106
633
115
732
2.45
8.21
3.0
2.1
98.88
94.59
pmol/l
0.43
69
363
118
760
2.46
8.20
5.1
3.0
116.15
109.66
ug/l
0.13
110
706
137
945
2.61
8.20
15.8
9.6
4.29
3.99
e9/l
0.60
120
834
58
271
2.64
8.09
2.1
1.7
897.14
1187.73
nmol/l
1.87
43
199
21
52
4.42
8.04
2.4
4.4
113.98
28.52
mg/l
0.56
21
46
21
52
4.42
8.04
2.4
4.4
51.40
152.34
mg/l
0.44
21
46
89
510
2.40
8.00
4.4
3.2
1476.51
1264.97
ng/l
0.31
78
431
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
19
30
6.91
7.95
4.1
2.2
0.37
0.32
iu/ml
—
9
16
29
94
3.46
7.67
5.4
2.4
128.28
128.73
g/l
0.03
29
89
51
229
2.68
7.66
15.6
5.6
104.41
104.06
mmol/l
0.22
51
229
27
86
3.49
7.32
1.9
1.3
—
—
—
0
0
19
34
6.09
7.29
2.4
1.5
—
—
—
0
0
31
109
3.20
7.20
5.9
3.1
103.37
80.66
ng/l
0.82
24
96
14
17
8.79
6.96
1.9
1.6
—
—
—
0
0
15
21
7.65
6.85
2.4
1.9
—
—
—
0
0
14
18
8.30
6.74
2.4
1.4
—
—
—
0
0
38
156
2.79
6.72
3.4
2.1
32.85
32.35
u/l
0.04
33
128
70
386
2.29
6.62
4.1
2.2
—
—
—
0
0
18
46
4.22
6.61
2.0
1.3
272.23
309.64
ug/g
0.31
13
30
126
887
2.25
6.44
6.5
3.8
0.00
0.02
estimate
0.50
21
180
19
52
3.95
6.38
1.5
1.1
—
—
—
0
0
9
5
18.79
6.32
1.4
2.0
—
—
—
0
0
9
5
18.79
6.32
1.4
2.0
—
—
—
0
0
40
174
2.65
6.31
3.3
2.7
8.06
6.34
umol/l
0.42
33
155
124
872
2.21
6.29
6.5
3.7
0.00
0.00
estimate
-0.00
23
194
99
638
2.15
6.28
5.9
3.8
43.69
46.69
ng/l
0.06
76
458
92
581
2.13
6.10
4.9
3.1
2.32
2.36
mmol/l
2.28
85
527
124
879
2.18
6.07
6.5
3.8
0.00
8.29
estimate
0.50
23
196
18
51
3.79
5.76
1.6
1.1
—
—
—
0
0
70
405
2.15
5.75
1.5
1.3
1.18
1.53
u/ml
0.16
14
103
12
16
7.92
5.73
2.3
2.0
—
—
—
0
0
131
962
2.16
5.68
3.8
3.0
—
—
—
0
0
12
17
7.45
5.53
2.3
1.9
—
—
—
0
0
12
17
7.45
5.53
2.3
1.9
—
—
—
0
0
156
1237
2.46
5.50
7.2
4.2
17.72
11.26
mm/h
3.24
148
1136
18
53
3.65
5.46
4.9
2.0
23.91
24.96
mmol/l
0.43
18
53
24
87
3.01
5.27
2.5
2.2
1.10
1.22
%
0.30
24
87
5
0
+∞
5.23
4.6
0.0
—
—
—
0
0
11
15
7.71
5.22
2.0
1.3
—
—
—
0
0
18
56
3.45
5.04
3.4
2.8
—
—
—
0
0
11
16
7.22
5.03
2.4
2.0
—
—
—
0
0
11
17
6.79
4.85
2.4
1.9
—
—
—
0
0
11
17
6.79
4.85
2.4
1.9
—
—
—
0
0
14
30
4.95
4.79
2.1
1.5
—
—
—
0
0
7
5
14.46
4.61
1.6
2.0
—
—
—
0
0
7
5
14.46
4.61
1.6
2.0
—
—
—
0
0
32
145
2.45
4.60
2.7
2.3
8.66
6.63
ug/l
0.32
27
126
137
1072
2.00
4.38
5.2
3.1
60.60
43.97
u/l
0.79
131
1006
8
9
9.21
4.32
1.6
1.9
16.88
11.33
u/l
—
8
9
13
30
4.57
4.21
1.8
1.2
—
—
—
0
0
104
752
1.85
4.15
5.0
2.6
—
—
estimate
—
0
0
20
75
2.86
4.14
1.3
1.4
—
—
—
0
0
12
26
4.85
4.13
1.8
1.1
438.57
320.78
u/ml
—
7
9
8
10
8.29
4.10
1.6
1.6
—
—
—
0
0
12
27
4.67
4.01
2.3
1.3
—
—
—
0
0
37
191
2.16
3.93
1.8
1.6
1.66
1.44
%
0.72
31
161
17
60
3.01
3.91
1.4
2.7
0.00
0.00
g/l
-0.00
17
53
12
28
4.50
3.89
2.1
1.5
—
—
—
0
0
57
347
1.92
3.86
3.2
2.7
2.41
2.45
mmol/l
1.71
52
313
7
8
9.03
3.80
1.0
1.3
—
—
—
0
0
15
50
3.17
3.78
3.0
1.8
—
—
—
0
0
24
104
2.50
3.78
22.5
7.6
0.62
0.66
%
0.18
24
104
13
34
4.03
3.77
2.2
1.4
—
—
—
0
0
19
73
2.78
3.77
1.6
1.7
6.90
6.94
iu/ml
—
6
17
52
310
1.93
3.73
1.2
1.3
29.71
26.34
iu/ml
—
7
98
33
169
2.15
3.56
2.5
1.9
341.93
380.39
nmol/l
0.56
27
157
24
108
2.40
3.49
22.3
7.4
1.43
1.40
%
0.04
24
108
15
53
2.99
3.44
9.4
2.4
8.65
8.47
kpa
0.15
15
53
9
18
5.19
3.41
1.9
1.7
—
—
—
0
0
8
14
5.91
3.37
2.8
1.4
0.61
0.59
e9/l
—
8
14
178
1595
2.84
3.27
39.9
13.7
26.77
22.96
mg/l
0.81
156
1297
148
1243
1.86
3.16
5.1
4.4
14.94
14.83
pmol/l
0.20
136
1110
169
1487
2.24
3.12
7.0
5.4
1.95
1.91
mu/l
0.15
161
1332
12
36
3.49
3.08
3.7
2.6
7.66
7.10
pmol/l
0.14
12
36
6
8
7.70
3.07
2.5
3.5
0.63
0.61
mmol/l
—
6
8
13
46
2.96
2.98
1.7
1.3
—
—
—
0
0
8
17
4.86
2.95
3.5
2.0
—
—
—
0
0
45
277
1.82
2.88
1.2
1.3
2.62
9.38
u/ml
1.61
13
113
14
53
2.77
2.86
2.7
1.9
—
—
—
0
0
13
48
2.83
2.78
3.4
2.5
196.46
191.90
%
0.05
13
48
11
34
3.37
2.77
3.0
2.5
14.80
16.11
%
0.66
11
34
5
6
8.51
2.76
1.2
1.5
—
—
—
0
0
5
6
8.51
2.76
2.6
2.0
—
—
—
0
0
5
6
8.51
2.76
3.6
1.3
—
—
—
0
0
7
14
5.15
2.75
3.9
2.2
—
—
—
0
0
50
322
1.75
2.74
2.2
1.7
460.93
44656924.96
pmol/l
0.50
45
262
76
552
1.63
2.65
5.8
3.8
14.10
8.56
mg/mmol
0.57
56
335
9
25
3.73
2.61
1.9
1.6
—
—
—
0
0
9
25
3.73
2.61
2.8
5.1
—
—
—
0
0
5
7
7.30
2.56
1.6
1.7
—
—
—
0
0
5
7
7.30
2.56
1.6
1.6
—
—
—
0
0
5
7
7.30
2.56
1.6
1.6
—
—
—
0
0
6
11
5.59
2.56
1.7
1.3
10.67
8.91
u/l
—
6
11
6
11
5.59
2.56
2.3
1.3
—
—
—
0
0
6
12
5.12
2.42
1.8
1.8
75.00
102.25
%
—
6
12
10
33
3.14
2.39
2.5
1.5
—
—
—
0
0
5
8
6.38
2.38
5.6
6.3
776.80
995.13
u/ml
—
5
8
7
17
4.23
2.38
1.0
1.2
—
—
—
0
0
11
40
2.86
2.31
8.3
2.1
—
—
—
0
0
19
94
2.13
2.25
1.0
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
9
5.67
2.22
1.0
1.3
—
—
—
0
0
5
10
5.10
2.08
1.2
3.1
62.40
254.40
nmol/l
—
5
10
6
15
4.09
2.05
1.0
1.1
—
—
—
0
0
176
1624
2.14
2.04
47.0
16.4
3.96
3.97
mmol/l
0.14
176
1587
176
1624
2.14
2.04
46.5
16.2
139.01
139.73
mmol/l
3.28
176
1589
8
26
3.17
2.04
1.3
1.5
—
—
—
0
0
8
26
3.17
2.04
1.3
1.1
—
—
—
0
0
8
26
3.17
2.04
1.3
1.5
—
—
—
0
0
27
159
1.81
1.98
3.3
2.2
—
—
—
0
0
6
16
3.84
1.95
1.2
1.1
—
—
—
0
0
7
22
3.26
1.90
1.1
1.5
—
—
—
0
0
5
12
4.25
1.83
3.6
1.6
—
—
—
0
0
7
23
3.12
1.81
1.3
1.2
—
—
—
0
0
11
47
2.42
1.81
1.3
1.3
—
—
—
0
0
6
18
3.41
1.76
1.0
1.2
—
—
—
0
0
163
1489
1.67
1.67
5.2
4.3
1.36
1.27
mmol/l
0.77
151
1356
84
676
1.43
1.64
7.2
3.7
0.00
0.01
estimate
0.50
18
167
5
14
3.64
1.62
1.8
1.4
271.80
245.91
u/l
—
5
14
5
14
3.64
1.62
1.6
1.8
—
—
—
0
0
5
14
3.64
1.62
1.6
1.8
—
—
—
0
0
5
14
3.64
1.62
1.6
1.8
—
—
—
0
0
7
27
2.65
1.53
1.0
1.3
—
—
—
0
0
166
1534
1.65
1.49
34.9
14.4
78.21
80.86
ml/min/173m2
0.70
154
1414
64
498
1.43
1.48
6.8
4.0
0.00
0.00
estimate
-0.00
23
174
7
28
2.56
1.46
1.0
1.3
—
—
—
0
0
5
16
3.18
1.44
1.0
1.1
—
—
—
0
0
6
22
2.78
1.44
1.0
1.3
—
—
—
0
0
26
169
1.62
1.38
6.4
3.0
—
—
—
0
0
5
17
2.99
1.36
1.4
1.4
—
—
—
0
0
62
486
1.41
1.36
6.1
3.3
0.00
0.01
estimate
0.50
22
157
163
1510
1.56
1.32
8.8
6.4
40.79
39.15
mmol/mol
1.20
156
1412
178
1686
1.88
1.31
47.5
18.5
87.74
76.19
umol/l
2.19
178
1662
6
24
2.55
1.31
1.0
1.3
—
—
—
0
0
6
24
2.55
1.31
1.0
1.3
—
—
—
0
0
6
24
2.55
1.31
1.2
1.1
—
—
—
0
0
6
24
2.55
1.31
1.0
1.3
—
—
—
0
0
5
18
2.82
1.29
1.4
1.6
—
—
—
0
0
5
18
2.82
1.29
1.4
1.2
—
—
—
0
0
14
77
1.88
1.29
4.8
2.0
—
—
—
0
0
167
1559
1.59
1.26
6.1
5.2
4.30
4.61
mmol/l
3.27
157
1446
5
19
2.67
1.22
1.8
2.3
110.20
105.42
mmol/l
—
5
19
5
19
2.67
1.22
1.8
2.3
1.24
1.20
mmol/l
—
5
19
16
94
1.77
1.22
4.9
2.0
—
—
—
0
0
166
1552
1.55
1.20
6.0
5.1
1.37
1.47
mmol/l
1.98
154
1425
169
1587
1.59
1.18
7.0
5.9
2.51
2.69
mmol/l
1.96
163
1463
26
176
1.55
1.18
3.7
2.2
—
—
—
0
0
50
387
1.40
1.17
6.3
3.9
1.02
1.02
kg/l
0.14
37
247
8
39
2.10
1.17
1.1
1.3
—
—
—
0
0
5
20
2.54
1.16
1.2
1.1
—
—
—
0
0
41
308
1.42
1.13
1.7
1.6
—
—
—
0
0
5
21
2.42
1.09
1.2
1.1
101.00
109.00
%
—
5
21
81
697
1.28
0.91
2.2
1.9
1.38
1.36
mmol/l
0.06
67
573
8
48
1.70
0.80
1.5
2.2
—
—
—
0
0
164
1560
1.37
0.76
6.2
5.1
6.21
5.90
mmol/l
1.43
152
1420
5
25
2.03
0.73
2.8
1.3
0.32
0.31
nmol/l
—
5
16
6
39
1.56
0.53
1.8
1.5
—
—
—
0
0
13
92
1.44
0.52
8.6
3.0
1.02
1.02
ratio
0.38
13
87
17
127
1.37
0.51
2.8
3.0
50.67
64.24
ml/min/173m2
—
9
50
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
5
36
1.40
0.38
1.0
1.1
—
—
—
0
0
23
194
1.21
0.31
16.3
7.4
—
—
—
0
0
11
141
0.77
0.30
1.5
1.4
—
—
—
0
0
24
209
1.17
0.24
4.3
4.7
29.37
31.99
%
0.62
19
126
21
240
0.86
0.22
1.5
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
3.3
—
1.00
—
0
11
0
10
0.00
0.21
0.0
1.3
—
223.33
—
0
10
45
428
1.07
0.11
3.4
4.7
21.44
21.73
%
0.03
16
208
5
47
1.07
0.09
1.4
1.4
—
—
—
0
0
33
321
1.03
0.02
2.4
3.3
0.55
0.75
ug/l
1.15
26
209
0
8
0.00
0.00
0.0
1.1
—
92.89
—
0
8
0
8
0.00
0.00
0.0
1.1
—
41.09
—
0
8
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
0.22
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: AB1_SEPSIS_PARAS_IMPL – Implicit parasitic Sepsis
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).